BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30663800)

  • 1. Hepatobiliary and Pancreatic: A procalcitonin-secreting and calcitonin-secreting pancreatic neuroendocrine carcinoma.
    Takahashi K; Ozawa E; Nakao K; Aoki S; Takase Y
    J Gastroenterol Hepatol; 2019 Jun; 34(6):964. PubMed ID: 30663800
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cushing syndrome caused by ACTH-expressing neuroendocrine pancreatic carcinoma with liver metastases].
    Fohr B
    Dtsch Med Wochenschr; 2007 May; 132(19):1053-4. PubMed ID: 17476637
    [No Abstract]   [Full Text] [Related]  

  • 3. ACTH-secreting neuroendocrine pancreatic tumor: a case report.
    Surace A; Ferrarese A; Benvenga R; Marola S; Cumbo J; Rivelli M; Martino V; Solej M; Nano M
    Int J Surg; 2014; 12 Suppl 1():S222-4. PubMed ID: 24866074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procalcitonin as an Alternative Tumor Marker of Medullary Thyroid Carcinoma.
    Giovanella L; Garo ML; Ceriani L; Paone G; Campenni' A; D'Aurizio F
    J Clin Endocrinol Metab; 2021 Nov; 106(12):3634-3643. PubMed ID: 34382653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy and clinical significance of the fine needle aspiration Ki-67 labelling index in pancreatic endocrine tumours.
    Kaklamanos M; Karoumpalis I; Salla C; Thomas D; Kanakis G; Alexandraki K; Sougioultzis S; Diakatou E; Kontogeorgos G; Kaltsas G
    Endocr Relat Cancer; 2011 Oct; 18(6):L1-3. PubMed ID: 22034543
    [No Abstract]   [Full Text] [Related]  

  • 6. Procalcitonin as a postoperative marker in the follow-up of patients affected by medullary thyroid carcinoma.
    Trimboli P; Lauretta R; Barnabei A; Valabrega S; Romanelli F; Giovanella L; Appetecchia M
    Int J Biol Markers; 2018 May; 33(2):156-160. PubMed ID: 29707993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mixed ductal endocrine carcinoma of the pancreas].
    Zehani A; Chelly I; Azouz H; Makni A; Haouet S; Kchir N
    Ann Pathol; 2012 Aug; 32(4):296-8. PubMed ID: 23010408
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulinoma-associated protein 1 immunostaining on cytology specimens: an institutional experience.
    Rodriguez EF; Fite JJ; Chowsilpa S; Maleki Z
    Hum Pathol; 2019 Mar; 85():128-135. PubMed ID: 30502379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computed tomography and magnetic resonance imaging features of lipid-rich neuroendocrine tumors of the pancreas.
    Fukukura Y; Shindo T; Higashi M; Takumi K; Umanodan T; Yoneyama T; Yoshiura T
    World J Gastroenterol; 2015 Sep; 21(34):10008-17. PubMed ID: 26379406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic thymic neuroendocrine carcinoma presenting as a pancreatic tumor.
    Lee YT; Tse GM; Lai PB; Sung JJ
    Endoscopy; 2006; 38 Suppl 2():E58-9. PubMed ID: 17366416
    [No Abstract]   [Full Text] [Related]  

  • 11. Cutaneous metastases of pancreatic neuroendocrine carcinoma.
    Laschinger ME; Naga L; Gaspari AA
    G Ital Dermatol Venereol; 2018 Oct; 153(5):722-724. PubMed ID: 30246953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State-of-the-art magnetic resonance imaging of pancreatic cancer.
    Schima W; Ba-Ssalamah A; Goetzinger P; Scharitzer M; Koelblinger C
    Top Magn Reson Imaging; 2007 Dec; 18(6):421-9. PubMed ID: 18303400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic Neuroendocrine Tumor Abnormally Secreting Procalcitonin.
    Hagiya H; Matsui T; Kitamura T; Inoue T; Shigekawa M; Yoshida H; Morii E; Tomono K
    Pancreas; 2017 Jan; 46(1):e7-e9. PubMed ID: 27977635
    [No Abstract]   [Full Text] [Related]  

  • 14. Extrathyroidal Calcitonin Secreting Tumors: Pancreatic Neuroendocrine Tumors in Patients With Multinodular Goiter: Two Case Reports.
    Giannetta E; Gianfrilli D; Pozza C; Lauretta R; Graziadio C; Sbardella E; Baroli A; Caronna R; Chirletti P; Lenzi A; Isidori AM
    Medicine (Baltimore); 2016 Jan; 95(3):e2419. PubMed ID: 26817871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine Carcinoma of the Gallbladder Accompanied by Pancreaticobiliary Maljunction.
    Matsumoto T; Imai Y; Inokuma T
    Clin Gastroenterol Hepatol; 2016 Mar; 14(3):e29-30. PubMed ID: 26247168
    [No Abstract]   [Full Text] [Related]  

  • 16. A malignant cause of hypoglycaemia: a metastatic insulin-secreting pancreatic neuroendocrine carcinoma.
    Sandoval MA; Pagsisihan D; Berberabe A; Palugod-Lopez EG
    BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 26994053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pancreatic mass and bilateral pitting pedal edema: nothing is ever what it seems.
    Gleeson FC; Brown CM; Herrera Hernandez LP
    Clin Gastroenterol Hepatol; 2012 Jan; 10(1):e3. PubMed ID: 21893133
    [No Abstract]   [Full Text] [Related]  

  • 18. Pancreatic neuroendocrine tumor mimicking a malignant intraductal papillary mucinous neoplasm.
    Kirchgesner J; Colignon N; Balladur P; Fléjou JF; Svrcek M
    Pancreatology; 2016; 16(2):290-2. PubMed ID: 26948577
    [No Abstract]   [Full Text] [Related]  

  • 19. Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using magnetic resonance imaging: The value of contrast-enhanced and diffusion weighted imaging.
    Guo C; Chen X; Wang Z; Xiao W; Wang Q; Sun K; Zhuge X
    Oncotarget; 2017 Jun; 8(26):42962-42973. PubMed ID: 28487490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary calcitonin-secreting neuroendocrine carcinoma of the supraglottic larynx.
    Hakeem AH; Pradhan S; Bhele S; Tubachi J
    Ear Nose Throat J; 2015 Jan; 94(1):E34-5. PubMed ID: 25606844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.